Rheumatology Biorepository-- For Healthy Volunteers AND those with Autoimmune and Rheumatic Disorders
This study is being done to provide resources for future studies involving autoimmune and rheumatic disorders, such as systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, Sjogren’s syndrome, vasculitis, and undifferentiated connective tissue diseases. The samples and data collected will be stored and used in the future to learn more about rheumatic and autoimmune disorders. Healthy volunteers are also being recruited.
- 18 years of age or older
If you decide to participate in this study, you will be asked to provide some samples*.
The samples you can provide for this study could be any or all of the following:
• Blood (up to approximately 10 tablespoons)
• Urine
• Stool
• Saliva (approximately 2 teaspoons)
• Skin biopsy
• Oral mucosa biopsy
• Medical waste (such as skin or synovial fluid)
*You can choose which types of samples you would like to provide.
Babies Helping Babies--A Study for Healthy Babies Under the Age of 2
This study is seeking babies who do NOT have infections. The purpose of this research study is to look at how the body responds to infection (immune response) caused by different types of microbes (bacteria and virus). To understand how the immune response to infection works, blood samples from people who have infections will be compared to blood samples from people who do not. You and your baby will have a one time/one hour visit at the Nationwide Children's Hospital.
- Age birth to 2 years
- Have been healthy for the past 3-4 weeks
- Do not have a chronic health condition
- Not born prematurely
Medication Study for the Symptoms of Systemic Lupus Erythematosus (SLE)
The purpose of this study is to test the effects of a new drug called CC-22. Researchers want to find out if it does or does not improve the symptoms of those diagnosed with Systemic Lupus Erythematosus (SLE).
You may be eligible for this study if:
You have been diagnosed with SLE
You have had SLE longer than (or equal to) six (6) months
You have three (3) or more tender joints at the baseline visit
You have skin manifestations of Lupus